{
    "organizations": [],
    "uuid": "4f98a9b0f12eeac43f357ae8893e5bc33651a981",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-adverum-biotechnologies-announces/brief-adverum-biotechnologies-announces-proposed-public-offering-idUSASB0C4JX",
    "ord_in_thread": 0,
    "title": "BRIEF-Adverum Biotechnologies Announces Proposed Public Offering",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - Adverum Biotechnologies Inc:\n* ADVERUM BIOTECHNOLOGIES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK\n* ADVERUM BIOTECHNOLOGIES - INTENDS TO GRANT UNDERWRITERS 30-DAY OPTION TO BUY UP TO ADDITIONAL 15% OF SHARES OF COMMON STOCK OFFERED IN PUBLIC OFFERING Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T05:35:00.000+02:00",
    "crawled": "2018-02-09T06:05:08.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "adverum",
        "biotechnology",
        "inc",
        "adverum",
        "biotechnology",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "stock",
        "adverum",
        "biotechnology",
        "intends",
        "grant",
        "underwriter",
        "option",
        "buy",
        "additional",
        "share",
        "common",
        "stock",
        "offered",
        "public",
        "offering",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}